INM InMed Pharmaceuticals
- 0.2949
- +0.0101+3.55%
- 0.3135
- +0.0186+6.31%
InMed Pharmaceuticals News
InMed Pharmaceuticals | 8-K: InMed Pharmaceuticals Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update
InMed Pharmaceuticals | 10-Q: Quarterly report
InMed Pharmaceuticals | 8-K: Current report
InMed Pharmaceuticals | 8-K: Current report
InMed Pharmaceuticals | 8-K: Current report
InMed Pharmaceuticals | 8-K: Current report
InMed Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director HULL ANDREW
InMed Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer HSU ERIC C
InMed Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer MANCINI ALEXANDRA DIANE JANET
InMed Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer Jagpal Netta
InMed Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director HULL ANDREW
InMed Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer ADAMS ERIC A
InMed Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
InMed Pharmaceuticals | 8-K: InMed Reports Second Fiscal Quarter 2024 Financial Results and Provides Business Update
InMed Pharmaceuticals | 10-Q: Quarterly report
InMed Pharmaceuticals | 8-K: Current report
InMed Pharmaceuticals | 8-K: Current report
InMed Pharmaceuticals | 8-K: Current report
InMed Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals
InMed Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Johnson Shane Aaron
Analysis
Price Target
No Data
